• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transportation and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
Hogan Lovells Engage 5.7.16
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transportation and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
  1. News
  2. COVID-19 threat prompts Florida’s Health Officials to expand telehealth under Emergency Order

COVID-19 threat prompts Florida’s Health Officials to expand telehealth under Emergency Order

17 March 2020
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Get link
    • Get QR Code
    • Download
    • Print

On Monday, March 16, 2020, Florida’s Surgeon General issued a rare Emergency Order (the Order) that allows certain out-of-state health care professionals to temporarily provide telehealth services to persons in Florida in order to prepare for, respond to, or mitigate the effects of COVID-19. The Order also allows certain Florida licensed physicians to use telehealth services instead of in-person examinations in limited circumstances to prescribe controlled substances for their patients or to re-certify qualified patients for medical marijuana use. The Order is in effect for 30 days, unless the Surgeon General decides to extend the Order.

Also on March 16, 2020, Florida’s Agency for Health Care Administration (AHCA) issued a draft Medicaid provider alert stating that “In order to reduce community-spread of the virus, the Agency (and its Medicaid health plans) will be postponing face-to-face provider-site visit requirements (e.g., enrollment, credentialing, etc.) until further notice. Whenever possible, these requirements will be met telephonically or through audio/visual technology.” AHCA also stated in the draft alert that AHCA will be issuing subsequent guidance related to telemedicine and other “flexibilities or service enhancements that will be enacted to ensure there is no disruption in care for Medicaid recipients in the event of workforce shortages or limitations in recipients seeking care in provider offices.” AHCA expects to formalize the draft Medicaid provider alert as part of a Medicaid Program Policy Transmittal soon.

The Surgeon General’s Order temporarily allows physicians, physician assistants, and advanced registered nurse practitioners who hold a valid, clear and unrestricted license in another U.S. state or territory to furnish telehealth services to persons in Florida even if such health care professionals are not registered with Florida’s Department of Health as out-of-state telehealth providers. In order to qualify, however, the health care professionals must not currently be under investigation or prosecution in any disciplinary proceeding, and they must comply with Florida’s scope of practice limitations. The Order is silent as to coverage and reimbursement for these telehealth services.

The Order increases access for Floridians to health care professionals through the use of telehealth. Without the Order, a health care professional not licensed in Florida would not be permitted under Florida law to conduct a telehealth service for a patient located in Florida unless that health care professional first registered with applicable Florida licensing board (e.g., the Board of Medicine or Board of Osteopathic Medicine). That registration process is typically time-consuming because it requires the out-of-state health care professional to complete and submit a registration application to the Department of Health and satisfy certain other registration requirements. The Order expressly waives the registration requirement for the qualifying out-of-state health care professionals, thereby immediately expanding access to needed services for Floridians through the use of telehealth.

The Order also allows Florida licensed physicians, physician assistants, and advanced registered nurse practitioners who have designated themselves as a “controlled substance prescribing practitioner” in accordance with Florida law to issue a renewal prescription for a controlled substance to an existing patient for the purpose of treating chronic malignant pain without the need to conduct an in-person physician examination and instead through the use of an examination through telehealth.

The Order also makes it temporarily possible for qualified physicians to use telehealth in order to provide medical marijuana for certain patients. Specifically, a “qualified physician” under Florida’s medical marijuana law may, for 30 days, use a telehealth visit to issue a physician certification for an existing qualified patient who already has an existing certification issued by the same qualified physician without the need to conduct an examination while physically present in the same room as the qualified patient.

* * *

For more information or guidance, please contact one of our Hogan Lovells professionals.

 

Authored by Craig Smith and Brooke Bumpers

Contacts
Craig Smith
Partner
Miami
Brooke Bumpers
Counsel
NW Washington, D.C.
Related Materials
PLEASE DO NOT USE: DUP_Medical Devices_ Doctor Viewing Computer Image

Telehealth promises faster, more convenient access to health care services

Pharma-Biotech_Clinical Trials (2)

The global impact of COVID-19 on clinical trials and countermeasure development

Keywords medical marijuana, telehealth, emergency order, covid-19, coronavirus, face-to-face, licensure, florida, ahca, surgeon general, qualified physician
Languages English
Topics Controlled Substances, Life Science Government Enforcement and Compliance, Digital Health, COVID-19
Countries United States
Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  • Contact us
  • Disclaimer
  • Privacy
  • Cookies
  • Legal Notices
  • Terms of Use

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2022 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.

Thomson Reuters HighQ Logo
© 2023 Hogan Lovells | Privacy Policy | Terms of Service